Moderna (MRNA) Prices 26.276M Share IPO at $23/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Moderna to raise $604 million in upsized IPO, braving market jitters
December 6, 2018 6:35 PM ESTBy Lance Tupper and Joshua Franklin
(Reuters) - Moderna Inc (OTC: MRNA) will sell around $604.3 million in shares in its initial public offering (IPO), the biotech company said on Thursday, braving stock market jitters to sell more stock than originally planned.
In the biggest flotation of a biotechnology company since 2016, Moderna said it would sell roughly 26.3 million shares at $23 per share. Moderna had originally planned to sell 21.7 million shares for between $22 and $24 per share.
Moderna is due to start trading on the Nasdaq on Friday under the ticker... More
Moderna (MRNA) considering upsizing IPO by around 20% - Reuters
December 6, 2018 1:12 PM ESTModerna (MRNA) considering upsizing IPO by around 20% - Reuters
... More